HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akihiro Ito Selected Research

Castration

11/2023Trends in the use of local intervention for metastatic hormone-naïve prostate cancer: A multicenter retrospective study.
1/2023Clinical significance of completion of radium-223 treatment and acute adverse events in patients with metastatic castration-resistant prostate cancer.
7/2022Machine learning diagnosis by immunoglobulin N-glycan signatures for precision diagnosis of urological diseases.
1/2022Effect of upfront intensive therapy on oncological outcomes in older patients with high tumor burden metastatic castration-sensitive prostate cancer: A multicenter retrospective study.
11/2021Clinical Impact of Detecting Low-Frequency Variants in Cell-Free DNA on Treatment of Castration-Resistant Prostate Cancer.
7/2021Stage-specific Embryogenic Antigen-4 Expression in Castration-resistant Prostate Cancer and its Correlation With the Androgen Receptor.
5/2021Impact of pretreatment anemia on upfront abiraterone acetate therapy for metastatic hormone-sensitive prostate cancer: a multicenter retrospective study.
7/2020Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration-sensitive prostate cancer: A multicenter retrospective study.
1/2020The Effect of Treatment Sequence on Overall Survival for Men With Metastatic Castration-resistant Prostate Cancer: A Multicenter Retrospective Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akihiro Ito Research Topics

Disease

81Neoplasms (Cancer)
04/2024 - 02/2002
39Prostatic Neoplasms (Prostate Cancer)
11/2023 - 02/2004
33Renal Cell Carcinoma (Grawitz Tumor)
04/2024 - 03/2002
18Neoplasm Metastasis (Metastasis)
01/2023 - 02/2002
16Pneumonia (Pneumonitis)
03/2024 - 07/2015
15Carcinoma (Carcinomatosis)
12/2022 - 02/2002
11Hyperaldosteronism (Conn Syndrome)
03/2024 - 07/2005
10Carcinogenesis
04/2023 - 11/2002
8Testicular Neoplasms (Testicular Cancer)
11/2023 - 05/2003
7Adenoma (Adenomas)
04/2024 - 07/2005
7Kidney Neoplasms (Kidney Cancer)
01/2023 - 03/2007
6Urinary Bladder Neoplasms (Bladder Cancer)
11/2023 - 06/2011
6Breast Neoplasms (Breast Cancer)
05/2022 - 10/2002
5Margins of Excision
11/2023 - 06/2012
5Hypertension (High Blood Pressure)
04/2023 - 07/2005
5Infections
01/2023 - 08/2010
5Adenocarcinoma
01/2023 - 06/2012
4Hemorrhage
01/2023 - 10/2015
4COVID-19
01/2023 - 01/2022
4Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
07/2022 - 07/2003
4Hypotension (Low Blood Pressure)
09/2021 - 01/2012
4Stomach Neoplasms (Stomach Cancer)
09/2019 - 01/2014
3Overactive Urinary Bladder (Overactive Bladder)
03/2024 - 12/2022
3Ischemia
03/2024 - 01/2019
3Inflammation (Inflammations)
01/2024 - 01/2013
3Non-Muscle Invasive Bladder Neoplasms
12/2023 - 11/2021
3Fever (Fevers)
02/2023 - 07/2015
3Disease Progression
05/2021 - 11/2014
3Cushing Syndrome
01/2021 - 01/2011
3Inguinal Hernia (Direct Inguinal Hernia)
08/2020 - 01/2012
3Lung Neoplasms (Lung Cancer)
09/2019 - 09/2008
3Lymphatic Metastasis
01/2019 - 11/2014
2Dyslipidemias (Dyslipidemia)
03/2024 - 08/2021
2Adrenocortical Carcinoma
01/2024 - 01/2022
2Ganglion Cysts (Ganglion)
11/2023 - 10/2016
2Erectile Dysfunction
11/2023 - 10/2016
2Urologic Neoplasms (Urological Cancer)
11/2023 - 11/2023
2Respiratory Insufficiency (Respiratory Failure)
10/2023 - 03/2017

Drug/Important Bio-Agent (IBA)

15Biomarkers (Surrogate Marker)IBA
04/2024 - 08/2008
13Hormones (Hormone)IBA
11/2023 - 10/2005
12AndrogensIBA
11/2023 - 03/2005
10EnzymesIBA
03/2024 - 03/2005
10Proteins (Proteins, Gene)FDA Link
10/2023 - 01/2012
9Prostate-Specific Antigen (Semenogelase)IBA
11/2023 - 05/2005
9AntigensIBA
10/2023 - 05/2005
9C-Reactive ProteinIBA
01/2023 - 11/2016
8AldosteroneIBA
04/2024 - 07/2005
8Tyrosine Kinase InhibitorsIBA
03/2024 - 02/2017
7Anti-Bacterial Agents (Antibiotics)IBA
03/2024 - 06/2013
7ProcalcitoninIBA
01/2023 - 11/2016
6Sirtuin 2IBA
03/2024 - 01/2016
6SteroidsIBA
10/2023 - 10/2015
6Cisplatin (Platino)FDA LinkGeneric
10/2021 - 06/2011
6Estrogens (Estrogen)FDA Link
01/2021 - 06/2006
5Prednisolone (Predate)FDA LinkGeneric
02/2023 - 01/2015
5CarbohydratesIBA
01/2020 - 02/2002
5GemcitabineFDA Link
01/2020 - 09/2006
5Monoclonal AntibodiesIBA
10/2019 - 02/2002
5GangliosidesIBA
01/2017 - 02/2002
4Histones (Histone)IBA
10/2023 - 03/2016
4Messenger RNA (mRNA)IBA
01/2023 - 11/2002
4Docetaxel (Taxotere)FDA Link
01/2022 - 09/2006
4stage-specific embryonic antigen-4IBA
07/2021 - 07/2003
4Sunitinib (Sutent)FDA Link
01/2021 - 02/2017
4Serum AlbuminIBA
06/2020 - 01/2017
4Forssman glycolipid (GL-5)IBA
01/2017 - 07/2003
3GlycosphingolipidsIBA
04/2024 - 02/2002
3ReninIBA
03/2024 - 07/2005
3Lysine (L-Lysine)FDA Link
10/2023 - 01/2012
3Transcription Factors (Transcription Factor)IBA
04/2023 - 11/2020
3Methotrexate (Mexate)FDA LinkGeneric
02/2023 - 06/2011
3Histone Acetyltransferases (Histone Acetyltransferase)IBA
05/2022 - 01/2017
3LuciferasesIBA
05/2022 - 01/2014
3Protein Isoforms (Isoforms)IBA
12/2021 - 01/2019
3Histone Deacetylases (Histone Deacetylase)IBA
10/2021 - 12/2014
3MacrolidesIBA
10/2021 - 07/2015
3Small Interfering RNA (siRNA)IBA
01/2020 - 06/2004
3AntibodiesIBA
01/2019 - 02/2002
3pirarubicinIBA
01/2018 - 04/2013
3Eukaryotic Translation Initiation Factor 5AIBA
01/2018 - 01/2016
3Carboplatin (JM8)FDA LinkGeneric
11/2014 - 10/2005
2Polysaccharides (Glycans)IBA
04/2024 - 07/2022
2LigandsIBA
03/2024 - 11/2010
2GlucocorticoidsIBA
01/2024 - 11/2011
2Opioid Analgesics (Opioids)IBA
11/2023 - 03/2017
2NivolumabIBA
11/2023 - 01/2023

Therapy/Procedure

51Therapeutics
03/2024 - 03/2005
21Prostatectomy (Retropubic Prostatectomy)
12/2022 - 02/2004
16Nephrectomy
11/2023 - 03/2002
11Drug Therapy (Chemotherapy)
11/2023 - 10/2004
11Adrenalectomy
02/2023 - 03/2002
9Castration
11/2023 - 01/2020
6Radiotherapy
11/2023 - 09/2006
6Lymph Node Excision (Lymph Node Dissection)
07/2023 - 05/2003
5Nephroureterectomy
01/2018 - 04/2013
3Aftercare (After-Treatment)
11/2023 - 01/2021
3Renal Dialysis (Hemodialysis)
09/2021 - 02/2017
3Intravesical Administration
01/2018 - 04/2013
3Orchiectomy (Orchidectomy)
04/2017 - 05/2003
2Salvage Therapy
11/2023 - 07/2013